Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cardiol Therapeutics Inc

1.08
+0.0000
Volume:63.39K
Turnover:66.90K
Market Cap:89.22M
PE:-3.03
High:1.08
Open:1.08
Low:1.03
Close:1.08
Loading ...

Company Profile

Company Name:
Cardiol Therapeutics Inc
Exchange:
NASDAQ
Establishment Date:
2017
Employees:
18
Office Location:
2265 Upper Middle Road East,Suite 602,Oakville,Ontario,Canada
Zip Code:
L6H 0G5
Fax:
905 481 2394
Introduction:
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.